Literature DB >> 10827165

Association between hepatitis B virus infection and HLA-DR type in Korea.

S H Ahn1, K H Han, J Y Park, C K Lee, S W Kang, C Y Chon, Y S Kim, K Park, D K Kim, Y M Moon.   

Abstract

Although the mechanism of susceptibility to chronic persistent hepatitis B virus (HBV) infection is not well clarified, immunogenetic factors of the host may have a role. Recently, a strong association between HLA-DR13 and the self-limited course of HBV infection has been reported. To determine whether the elimination of HBV is related to a particular HLA allele, we studied the HBV markers and HLA-DR phenotypes of 1,272 Koreans who had visited Yonsei University Medical Center for renal transplantation. They included 330 renal transplant donors. Subjects were categorized into 3 different groups: the "Unexposed Group" (UE; n = 946) with negative HBV markers, the "Chronic Carrier Group" (CC; n = 83), who were hepatitis B surface antigen (HBsAg)-positive, and the "Spontaneously Cleared Group" (SC; n = 243), who were HBsAg-negative with antibodies to HBsAg (anti-HBs) and hepatitis B core antigen (anti-HBc). HLA-DR4 was the most common type in all groups. HLA-DR6 was significantly more frequent in 69 of 243 subjects with SC (28. 4%) than in 8 of 83 subjects with CC (9.6%) (P <.001; relative risk [RR] = 3.72). HLA-DR9 was significantly more frequent in CC than in SC (P <.001; RR = 0.33). HLA-DR13 showed a stronger association with the clearance of HBV than the other HLA-DR6 subgroup. The distribution of HLA-DR phenotypes was similar regardless of renal disease. Our data indicate that HLA-DR6, especially HLA-DR13, is one of the host factors, which influences the immune response to HBV, and may be associated with self-elimination of HBV in Koreans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10827165     DOI: 10.1053/jhep.2000.7988

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  35 in total

1.  Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population.

Authors:  Xiuchan Guo; Yong Zhang; Ji Li; Jingchen Ma; Zuli Wei; Wenjie Tan; Stephen J O'Brien
Journal:  Hepatology       Date:  2011-01-04       Impact factor: 17.425

Review 2.  Quantification of HBsAg: basic virology for clinical practice.

Authors:  Jung Min Lee; Sang Hoon Ahn
Journal:  World J Gastroenterol       Date:  2011-01-21       Impact factor: 5.742

Review 3.  Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection.

Authors:  Fu-Sheng Wang
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

4.  Polymorphism in intron 1 of the interferon-gamma gene influences both serum immunoglobulin E levels and the risk for chronic hepatitis B virus infection in Polynesians.

Authors:  William Abbott; Edward Gane; Ingrid Winship; Stephen Munn; Colin Tukuitonga
Journal:  Immunogenetics       Date:  2007-01-09       Impact factor: 2.846

5.  Host susceptibility to persistent hepatitis B virus infection.

Authors:  Ying-Li He; Ying-Ren Zhao; Shu-Lin Zhang; Shu-Mei Lin
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

6.  In vivo inhibition of anti-hepatitis B virus core antigen (HBcAg) immunoglobulin G production by HBcAg-specific CD4(+) Th1-type T-cell clones in a hu-PBL-NOD/SCID mouse model.

Authors:  T Cao; P Meuleman; I Desombere; M Sällberg; G Leroux-Roels
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

7.  Association between polymorphism of tumor necrosis factor-alpha promoter and response to lamivudine treatment in patients with chronic hepatitis B.

Authors:  Yong Kwang Park; Jung Min Lee; Do Young Kim; Hye Young Chang; Ja Kyung Kim; Chun Kyon Lee; Jun Yong Park; Sang Hoon Ahn; Kwan Sik Lee; Kwang Hyub Han
Journal:  Dig Dis Sci       Date:  2009-10-15       Impact factor: 3.199

Review 8.  Hepatitis B virus infection in US correctional facilities: a review of diagnosis, management, and public health implications.

Authors:  Shaili Gupta; Frederick L Altice
Journal:  J Urban Health       Date:  2009-01-28       Impact factor: 3.671

Review 9.  A rationalized approach to the treatment of patients infected with hepatitis B.

Authors:  Natravis R Cox; Keyur Patel; Hans L Tillmann
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

10.  Polymorphisms of killer cell immunoglobulin-like receptor gene: possible association with susceptibility to or clearance of hepatitis B virus infection in Chinese Han population.

Authors:  Lu Zhi-ming; Jiao Yu-lian; Feng Zhao-lei; Wu Chun-xiao; Dong Zhen-fang; Zhang Bing-chang; Zhao Yue-ran
Journal:  Croat Med J       Date:  2007-12       Impact factor: 1.351

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.